Less Ads, More Data, More Tools Register for FREE

Synairgen Share News (SNG)

Synairgen Information

Buy SNG Shares
Add SNG to Watchlist
Add SNG to Alert

Share Price Information for Synairgen (SNG)

London Stock Exchange

Share Price is delayed by 15 minutes

Share Price: 6.60

Bid: 0.00

Ask: 0.00

Change: 0.00 (0.00%)

Spread: 1.16 (19.269%)

Open: 0.00

High: 0.00

Low: 0.00

Prev. Close: 6.60

SNG Live Price

Last checked at -

22 Jul 2015 10:44

AstraZeneca starts next phase of testing on Synairgen asthma drug

(ShareCast News) - Synairgen announced AstraZeneca started another phase of testing on its asthma drug. AIM listed Synairgen said AstraZeneca begun its Phase IIa trial of the drug AZD9412 and expected results in early 2017. AstraZeneca would test 220 asthma patients whose conditions were exacerbate

22 Jul 2015 07:00

Synairgen Says AstraZeneca Begins Phase IIa Trial In Severe Asthma

22 Jun 2015 07:28

LONDON BRIEFING: Stocks Surge On Optimism For Greek Debt Deal

22 Jun 2015 05:13

AGM, EGM Calendar - Week Ahead

19 Jun 2015 15:14

AGM, EGM Calendar - Week Ahead

19 Jun 2015 05:21

AGM, EGM Calendar - Week Ahead

18 Jun 2015 15:06

AGM, EGM Calendar - Week Ahead

18 Jun 2015 05:27

AGM, EGM Calendar - Week Ahead

17 Jun 2015 14:56

AGM, EGM Calendar - Week Ahead

17 Jun 2015 05:23

AGM, EGM Calendar - Week Ahead

16 Jun 2015 15:03

AGM, EGM Calendar - Week Ahead

16 Jun 2015 05:23

AGM, EGM Calendar - Week Ahead

15 Jun 2015 14:52

AGM, EGM Calendar - Week Ahead

3 Mar 2015 08:38

Synairgen Swings To 2014 Pretax Profit On AstraZeneca Licence Deal

21 Oct 2014 08:50

Tuesday broker round-up UPDATE

African Barrick Gold: JP Morgan cuts target price from 340p to 300p and stays with its overweight rating. Anglo American: JP Morgan raises target price from 1240p to 1310p, while leaving its underweight rating unchanged. Investec increases target price from 1573p to 1603p and stays with its buy reco